AAO: One Year of Valacyclovir Beneficial for Herpes Zoster Ophthalmicus
Significant treatment benefits seen at 18 months; in addition, risk for experiencing subsequent end points lower with valacyclovir
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.